Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOC FARM ITALIA
Pfizer Italia SRL
Original Assignee
SOC FARM ITALIA
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOC FARM ITALIA, Farmaceutici Italia SpAfiledCriticalSOC FARM ITALIA
Publication of ES332018A1publicationCriticalpatent/ES332018A1/es
C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
ES0332018A1965-10-071966-10-06Un procedimiento para preparar nuevos compuestos de accion pigmentante.
ExpiredES332018A1
(es)
Un procedimiento de preparacion de n1nl(-)-2-hidroxi-4-ami- no-butiroiln4-0n2', 6'-diamino-2', 6'-disesoxi-alfa, d-glu- copirano-siln6-0n3"-metilamino-3", 4",6"-tridesoxi-alfa-d- xilohexopiranosiln2-desoxi-estrepamina.
A process for the preparation of unsaturated derivatives of 2-methyl-2-hydroxy-3-halogen-teterahydrofurane and for their conversion to vitamin b and the like